Introduction The use of social media during the COVID-19 pandemic has led to an "infodemic" of mis- and disinformation with potentially grave consequences. To explore means of counteracting disinformation, we analyzed tweets containing the hashtags #Scamdemic and #Plandemic. Methods Using a Twitter scraping tool called twint, we collected 419,269 English-language tweets that contained “#Scamdemic” or “#Plandemic” posted in 2020. Using the Twitter application-programming interface, we extracted the same tweets (by tweet ID) with additional user metadata. We explored descriptive statistics of tweets including their content and user profiles, analyzed sentiments and emotions, performed topic modeling, and determined tweet availability in both datasets. Results After removal of retweets, replies, non-English tweets, or duplicate tweets, 40,081 users tweeted 227,067 times using our selected hashtags. The mean weekly sentiment was overall negative for both hashtags. One in five users who used these hashtags were suspended by Twitter by January 2021. Suspended accounts had an average of 610 followers and an average of 6.7 tweets per user, while active users had an average of 472 followers and an average of 5.4 tweets per user. The most frequent tweet topic was “Complaints against mandates introduced during the pandemic” (79,670 tweets), which included complaints against masks, social distancing, and closures. Discussion While social media has democratized speech, it also permits users to disseminate potentially unverified or misleading information that endangers people’s lives and public health interventions. Characterizing tweets and users that use hashtags associated with COVID-19 pandemic denial allowed us to understand the extent of misinformation. With the preponderance of inaccessible original tweets, we concluded that posters were in denial of the COVID-19 pandemic and sought to disperse related mis- or disinformation resulting in suspension. Conclusion Leveraging 227,067 tweets with the hashtags #scamdemic and #plandemic in 2020, we were able to elucidate important trends in public disinformation about the COVID-19 vaccine.
We used sentiment analysis and topic modeling to geospatially explore Ivermectin Twitter discourse in the United States and compared it to the political leaning of a state based on the 2020 presidential election. All modeled topics were associated with a negative sentiment. Tweets originating from democratic leaning states were more likely to be negative. Real-time analysis of social media content can identify public health concerns and guide timely public health interventions tackling disinformation.
Background The percentage of children infected with COVID-19 has outpaced that of adults. As children >5 years are now eligible to receive vaccines, it is necessary to understand the effect of vaccination in the context of demographic characteristics, clinical factors, and variants on pediatric COVID-19 illness severity. Methods We conducted a descriptive study of patients ≤18 years from the Optum® COVID-19 electronic health record dataset. Patients were included if positive for COVID-19 by polymerase chain reaction or antigen testing for the first time from 3/12/2020 to 1/20/2022. We compare race and ethnicity, age, gender, US region of residence, vaccination status, body mass index (BMI), pediatric comorbidity index (PCI) (Sun, Am. J. Epidemiol. 2021), and predominant variant (by time and region) with 2-tailed t-test, multi-category chi-square test, and odds ratios (R version 4.1.2; α = 0.05). PCI is a validated comorbidity index predicting hospitalization in pediatric patients. Results Of all pediatric patients in our dataset, 165,468 (13.2%) tested positive for COVID-19. 3,087 (1.9%) were hospitalized, 1,417 (0.9%) were admitted to the ICU, 1545 (0.9%) received respiratory support, and 31 (0.02%) died, comparable to AAP-reported hospitalization and mortality rates in US children. Patients with severe outcomes were more likely to be younger, non-Caucasian, from the US South, unvaccinated, and have a higher PCI (Figure 1). Excluding non-severe outcomes, rates of death and ICU admission were higher in 0–4-year-olds compared to 5–11 or 12–18-year-olds (Figure 2). All patients receiving at least one dose of the vaccine survived. The odds ratio of a severe outcome is 0.11 (95% CI 0.07–0.16) in fully vaccinated patients compared to unvaccinated patients. The odds ratio of a severe outcome is 0.55 (95% CI 0.49–0.63) in partially vaccinated patients compared to unvaccinated patients. Demographic and clinical characteristics of pediatric patients with COVID-19 Relative proportion of clinically severe outcomes within age groups, excluding non-severe outcomes Conclusion In this large population, incidence rate of severe outcomes from COVID-19 in pediatric patients was higher among non-Caucasian patients, living in the South, with underlying comorbid illness, and those not yet eligible for vaccination. These findings reinforce the need for a vaccine for younger patients and targeted vaccine outreach to racial and ethnic minorities and children with chronic conditions. Disclosures Christoph U. Lehmann, MD, Celanese: Stocks/Bonds|Markel: Stocks/Bonds|Springer: Honoraria|UTSW: Employee.
Background As the risk for concomitant COVID-19 infection in people living with HIV (PLHIV) remains largely unknown, we explored a large national database to identify risk factors for COVID-19 infection among PLHIV. Methods Using the COVID-19 OPTUM de-identified national multicenter database, we identified 29,393 PLHIV with either a positive HIV test or documented HIV ICD9/10 codes. Using a multiple logistic regression model, we compared risk factors among PLHIV, who tested positive for COVID-19 (5,134) and those who tested negative (24,259) from January 20, 2020, to January 20, 2022. We then compared secondary outcomes including hospitalization, Intensive Care Unit (ICU) stay, and death within 30 days of test among the 2 cohorts, adjusting for COVID-19 positivity and covariates. We adjusted all models for the following covariates: age, gender, race, ethnicity, U.S. region, insurance type, adjusted Charlson Comorbidity Index (CCI), Body Mass Index (BMI), and smoking status. Results Among PLHIV, factors associated with higher odds for acquiring COVID-19 (Figure 1) included lower age (compared to age group 18–49, age groups 50–64 and >65 were associated with odds ratios (OR) of 0.8 and 0.75, P= 0.001), female gender (compared to males, OR 1.06, P= 0.07), Hispanic White ethnicity/race (OR 2.75, P= 0.001), Asian (OR 1.35, P= 0.04), and African American (OR 1.23, P= 0.001) [compared to non-Hispanic White], living in the U.S. South (compared to the Northeast, OR 2.18, P= 0.001), being uninsured (compared to commercial insurance, OR 1.46, P= 0.001), higher CCI (OR 1.025, P= 0.001), higher BMI category (compared to having BMI< 30, Obesity category 1 or 2, OR 1.2 and obesity category 3, OR 1.34, P= 0.001), and noncurrent smoking status (compared to current smoker, OR 1.46, P= 0.001). Compared to PLHIV who tested negative for COVID-19, PLHIV who tested positive, had an OR 1.01 for hospitalization (P = 0.79), 1.03 for ICU stay (P=0.73), and 1.47 for death (P=0.001). Conclusion Our study found that among PLHIV, being Hispanic, living in the South, lacking insurance, having higher BMI, and higher CCI scores were associated with increased odds of testing positive for COVID-19. PLHIV who tested positive for COVID-19 had higher odds of death. Disclosures Christoph U. Lehmann, MD, Celanese: Stocks/Bonds|Markel: Stocks/Bonds|Springer: Honoraria|UTSW: Employee Jeremy Y. Chow, M.D., M.S., Gilead Sciences: Grant/Research Support.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.